Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s

QR Code

Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Natja Haag, Hans Zempel
Format:	article
Langue:	EN
Publié:	Nature Publishing Group 2021
Sujets:	Medicine R Biology (General) QH301-705.5
Accès en ligne:	https://doaj.org/article/bba88638db8746a6890aa0b5c7f5d91c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
par: Amit Pal, et autres
Publié: (2021)

Microglia astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
par: VON BERNHARDI,ROMMY, et autres
Publié: (2001)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
par: Guimei Zhang, et autres
Publié: (2021)

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
par: Grzegorz A. Czapski, et autres
Publié: (2021)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
par: Qinqin Wang, et autres
Publié: (2021)

N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
par: Ju Youn Lee, et autres
Publié: (2020)

Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer’s Disease Pathogenesis?
par: Lucrezia Bruno, et autres
Publié: (2021)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
par: Joseph Martin Alisky
Publié: (2008)

Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
par: Tyler K. Ulland, et autres
Publié: (2021)

Microglia Mediate the Occurrence and Development of Alzheimer’s Disease Through Ligand-Receptor Axis Communication
par: Chongdong Jian, et autres
Publié: (2021)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
par: Geraldine Zimmer-Bensch, et autres
Publié: (2021)

Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease
par: Dragan Gamberger, et autres
Publié: (2017)

Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease
par: Nicholas F. Fitz, et autres
Publié: (2021)

Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
par: Marta Olah, et autres
Publié: (2020)

Corrigendum: Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication
par: Chongdong Jian, et autres
Publié: (2021)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
par: Mannu P, et autres
Publié: (2011)

Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease
par: Jaymie R. Voorhees, et autres
Publié: (2019)

MODERN IDEAS OF “SLOW SLEEP” AND “REM-SLEEP” AND THEIR ROLE IN PATHOGENESIS OF ALZHEIMER’S DISEASE (REVIEW OF LITERATURE)
par: I. M. Madaeva, et autres
Publié: (2017)

Rivastigmine in the treatment of Alzheimer's disease: an update
par: Maria Luisa Onor, et autres
Publié: (2007)

Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin
par: Xiao Liu, et autres
Publié: (2021)

Biomarkers in Alzheimer’s disease
par: Janeiro Manuel H., et autres
Publié: (2020)

Journal of Alzheimer's disease
Publié: (1998)

Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
par: Tai Kyoung Kim, et autres
Publié: (2021)

Liposome delivery systems for the treatment of Alzheimer’s disease
par: Ross C, et autres
Publié: (2018)

Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
par: Simona Rossi, et autres
Publié: (2021)

Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model
par: Guillaume Etter, et autres
Publié: (2019)

Therapeutic efficacy of repetitive transcranial magnetic stimulation in an animal model of Alzheimer’s disease
par: Jin Seung Choung, et autres
Publié: (2021)

Controlling Alzheimer’s Disease Through the Deep Brain Stimulation to Thalamic Relay Cells
par: XiaoLi Yang, et autres
Publié: (2021)

Application of repetitive transcranial magnetic stimulation treatment benefits language performance in Alzheimer’s disease: a case study
par: Georgia Roumpea, et autres
Publié: (2021)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
par: Hannah Walgrave, et autres
Publié: (2021)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
par: Koppel J, et autres
Publié: (2014)

Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
par: Kevin A. Guttenplan, et autres
Publié: (2020)

The great reset: Transcranial pulse stimulation reduces global EEG-entropy in Alzheimer's Disease
par: Lars Wojtecki, et autres
Publié: (2021)

Alzheimer's disease: Newer biomarkers
par: Ankit Dangi, et autres
Publié: (2021)

Disentangling Mitochondria in Alzheimer’s Disease
par: Ashu Johri
Publié: (2021)

International journal of Alzheimer's disease

Neuroinflammation in Alzheimer’s disease
par: Zhang FJ, et autres
Publié: (2015)

Pathogenesis of Alzheimer′s disease
par: Russell H Swerdlow
Publié: (2007)

The genetics of Alzheimer's disease
par: Bagyinszky E, et autres
Publié: (2014)